Radiance Therapeutics,Inc. is developing a proprietary device utilizing clinically-proven brachytherapy to treat glaucoma. Glaucoma is the leading cause of blindness. There were an estimated 60.5 million people with glaucoma in 2010 and the therapeutic market is approximately $4.5B/year.



View Details...